Joint pain
Two of the six vouchers in the second round went to GLP-1 drugs: Novo Nordisks semaglutide, directed toward a higher-dose formulation of Wegovy, and Eli Lillys orforglipron, an oral non-peptide small molecule that had not yet received FDA approval
2 Every FSA/HSA plan is unique, and Noom does not provide medical, healthcare benefit, or tax advice to individuals
(PubMed) Teikari JM, Rautalahti M, Haukka J, et al
Some analyses show a reduced risk of pulmonary embolism with GLP-1 use, while one 2025 meta-analysis found a significantly higher DVT risk in patients who had been on these medications for more than 78 weeks
1 As the incidence of HF increases with age, the expected doubling in the number of people in the US aged 65 and older over the next decade will only exacerbate this burden